Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC

Clinical trial NCT02039336 · COMPLETED

Trial details

NCT number: NCT02039336
Sponsor: The Netherlands Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2014-04-02
Primary completion: 2018-08-07
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.